Literature DB >> 11905820

Cross-presentation in viral immunity and self-tolerance.

W R Heath1, F R Carbone.   

Abstract

T lymphocytes recognize peptide antigens presented by class I and class II molecules encoded by the major histocompatibility complex (MHC). Classical antigen-presentation studies showed that MHC class I molecules present peptides derived from proteins synthesized within the cell, whereas MHC class II molecules present exogenous proteins captured from the environment. Emerging evidence indicates, however, that dendritic cells have a specialized capacity to process exogenous antigens into the MHC class I pathway. This function, known as cross-presentation, provides the immune system with an important mechanism for generating immunity to viruses and tolerance to self.

Mesh:

Substances:

Year:  2001        PMID: 11905820     DOI: 10.1038/35100512

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  143 in total

Review 1.  Exploiting dendritic cells to improve vaccine efficacy.

Authors:  Ralph M Steinman; Melissa Pope
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

2.  Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo.

Authors:  Yu-Zhang Wu; Jian-Ping Zhao; Ying Wan; Zheng-Cai Jia; Wei Zhou; Jiang Bian; Bing Ni; Li-Yun Zou; Yan Tang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Cellular protein is the source of cross-priming antigen in vivo.

Authors:  Lianjun Shen; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

Review 4.  Routes to transplant tolerance versus rejection; the role of cytokines.

Authors:  Patrick T Walsh; Terry B Strom; Laurence A Turka
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

5.  Promiscuous binding of extracellular peptides to cell surface class I MHC protein.

Authors:  Herman N Eisen; Xun Helen Hou; Chase Shen; Kaidi Wang; Varsha Keelara Tanguturi; Crysela Smith; Katerina Kozyrytska; Lakshmi Nambiar; Carol A McKinley; Jianzhu Chen; Richard J Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-07       Impact factor: 11.205

6.  Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

Authors:  L Buonaguro; M L Tornesello; M Tagliamonte; R C Gallo; L X Wang; R Kamin-Lewis; S Abdelwahab; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 7.  Natural endogenous adjuvants.

Authors:  Kenneth L Rock; Arron Hearn; Chun-Jen Chen; Yan Shi
Journal:  Springer Semin Immunopathol       Date:  2004-10-14

Review 8.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

Review 9.  T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity.

Authors:  Jasper G van den Boorn; I Caroline Le Poole; Rosalie M Luiten
Journal:  Int Rev Immunol       Date:  2006 May-Aug       Impact factor: 5.311

10.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.